Network-guided modeling allows tumor-type independent prediction of sensitivity to all-trans-retinoic acid

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Annals of Oncology

• Publication date

  2016-12-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/annonc/mdw660PMID 27993792PMCID PMC5834014
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Uveal melanoma: From diagnosis to treatment and the science in between

  2016cited by this paper
• Serum RARRES2 Is a Prognostic Marker in Patients With Adrenocortical Carcinoma.

  2016cited by this paper
• Cellular and molecular determinants of all-trans retinoic acid sensitivity in breast cancer: Luminal phenotype and RARα expression

  2015cited by this paper
• Evaluation of 9-cis retinoic acid and mitotane as antitumoral agents in an adrenocortical xenograft model.

  2015cited by this paper
• Retinoids and breast cancer: from basic studies to the clinic and back again.

  2014cited by this paper
• Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.

  2013cited by this paper
• Synergistic antitumor activity of lapatinib and retinoids on a novel subtype of breast cancer with coamplification of ERBB2 and RARA

  2012cited by this paper
• The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity

  2012cited by this paper
• Cytodifferentiation by retinoids, a novel therapeutic option in oncology: rational combinations with other therapeutic agents.

  2007cited by this paper
• Different ways to induce apoptosis by fenretinide and all-trans-retinoic acid in human B lymphoma cells.

  2005cited by this paper
• ARACNE: An Algorithm for the Reconstruction of Gene Regulatory Networks in a Mammalian Cellular Context

  2004cited by this paper
• Human B-cell lymphoma cell lines are highly sensitive to apoptosis induced by all-trans retinoic acid and interferon-gamma.

  2002cited by this paper
• Human B-cell lymphoma cell lines are highly sensitive to apoptosis induced by all-trans retinoic acid and interferon-γ

  2002cited by this paper
• Modulation of retinoid signalling through NGF-induced nuclear export of NGFI-B

  2000cited by this paper

• Roscovitine derivative optimization via molecular dynamics reveals potent and selective CDK5 binders

  2026cites this paper
• Dysregulation of the ALDH1A3/PML-RARα axis promotes the progression of acute promyelocytic leukemia.

  2026cites this paper
• Lignin-Derived Oligomers as Promising mTOR Inhibitors: Insights from Dynamics Simulations

  2025cites this paper
• Cellular and micro-environmental responses influencing the antitumor activity of all-trans retinoic acid in breast cancer

  2024cites this paper
• Machine learning-based pan-cancer study of classification and mechanism of BRAF inhibitor resistance

  2024cites this paper
• HPC-T-Annotator: an HPC tool for de novo transcriptome assembly annotation

  2024cites this paper
• Clinical Applications of Machine Learning in the Management of Intraocular Cancers: A Narrative Review

  2023cites this paper
• Anti-tumor activity of all-trans retinoic acid in gastric-cancer: gene-networks and molecular mechanisms

  2023cites this paper
• iUMRG: multi-layered network-guided propagation modeling for the inference of susceptibility genes and potential drugs against uveal melanoma

  2022cites this paper
• hTERT DNA Methylation Analysis Identifies a Biomarker for Retinoic Acid-Induced hTERT Repression in Breast Cancer Cell Lines

  2022cites this paper
• Уровни белков CRABP1 и CRABP2 не коррелируют с чувствительностью клеток рака молочной железы к ретиноевой кислоте, но коррелируют между собой, причем CRABP2 является регулятором продукции CRABP1

  2021cites this paper
• Retinoic Acid Downregulates HSPB8 Gene Expression in Human Breast Cancer Cells MCF-7

  2021cites this paper
• CRABP1 and CRABP2 Protein Levels Correlate with Each Other but Do Not Correlate with Sensitivity of Breast Cancer Cells to Retinoic Acid

  2021cites this paper
• Study and analysis of antitumor resistance mechanism of PD1/PD‐L1 immune checkpoint blocker

  2020cites this paper
• A novel cyclic peptide targeting LAG-3 for cancer immunotherapy by activating antigen-specific CD8+ T cell responses

  2020cites this paper
• All-Trans Retinoic Acid Stimulates Viral Mimicry, Interferon Responses and Antigen Presentation in Breast-Cancer Cells

  2020influential citation
• Current Trends in ATRA Delivery for Cancer Therapy

  2020cites this paper
• Retinoic Acid Sensitivity of Triple-Negative Breast Cancer Cells Characterized by Constitutive Activation of the notch1 Pathway: The Role of Rarβ

  2020cites this paper
• Network-based machine learning in colorectal and bladder organoid models predicts anti-cancer drug efficacy in patients

  2020cites this paper
• Minimal information for Chemosensitivity assays (MICHA): A next-generation pipeline to enable the FAIRification of drug screening experiments

  2020cites this paper
• Anti-tumour effects of all-trans retinoid acid on serous ovarian cancer

  2019cites this paper
• Combinational treatment of all-trans retinoic acid (ATRA) and bisdemethoxycurcumin (BDMC)-induced apoptosis in liver cancer Hep3B cells.

  2019cites this paper
• Targeting Angiogenesis by Blocking the ATM–SerRS–VEGFA Pathway for UV-Induced Skin Photodamage and Melanoma Growth

  2019cites this paper
• Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid

  2019cites this paper
• The ATRA-21 gene-expression model predicts retinoid sensitivity in CEBPA double mutant, t(8;21) and inv(16) AML patients

  2019cites this paper
• Guidance factors orchestrating regulatory T cell positioning in tissues during development, homeostasis, and response

  2019cites this paper
• Synergy from gene expression and network mining (SynGeNet) method predicts synergistic drug combinations for diverse melanoma genomic subtypes

  2019cites this paper
• The effects of all-trans retinoic acid on estrogen receptor signaling in the estrogen-sensitive MCF/BUS subline

  2018cites this paper
• Dermatology today and tomorrow: from symptom control to targeted therapy

  2018cites this paper
• HER2-positive breast-cancer cell lines are sensitive to KDM5 inhibition: definition of a gene-expression model for the selection of sensitive cases

  2018cites this paper
• S100A3 a partner protein regulating the stability/activity of RARα and PML-RARα in cellular models of breast/lung cancer and acute myeloid leukemia

  2018cites this paper
• Artificial Intelligence Approaches in Hematopoietic Cell Transplantation: A Review of the Current Status and Future Directions

  2018cites this paper
• Profiling of the transcriptional response to all-trans retinoic acid in breast cancer cells reveals RARE-independent mechanisms of gene expression

  2017cites this paper